I 
117TH CONGRESS 
1ST SESSION H. R. 2883 
To enable the Federal Trade Commission to deter filing of sham citizen 
petitions to cover an attempt to interfere with approval of a competing 
generic drug or biosimilar, to foster competition and facilitate the effi-
cient review of petitions filed in good faith to raise legitimate public 
heath concerns, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 28, 2021 
Mr. JEFFRIES (for himself, Mr. BUCK, Mr. NADLER, Mr. CICILLINE, and Mrs. 
CAROLYN B. MALONEY of New York) introduced the following bill; which 
was referred to the Committee on the Judiciary 
A BILL 
To enable the Federal Trade Commission to deter filing 
of sham citizen petitions to cover an attempt to interfere 
with approval of a competing generic drug or biosimilar, 
to foster competition and facilitate the efficient review 
of petitions filed in good faith to raise legitimate public 
heath concerns, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Stop Stalling Access 
to Affordable Medications’’. 
VerDate Sep 11 2014 
23:32 Jun 08, 2021
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H2883.IH
H2883
kjohnson on DSK79L0C42PROD with BILLS
SEC. 2. FEDERAL TRADE COMMISSION ENFORCEMENT 
AGAINST SHAM PETITIONS. 
(a) DEFINITIONS.—In this section: 
(1) COMMISSION.—The term ‘‘Commission’’ 
means the Federal Trade Commission. 
(2) COVERED APPLICATION.—The term ‘‘cov-
ered application’’ means an application filed pursu-
ant to subsection (b)(2) or (j) of section 505 of the 
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
355) or section 351(k) of the Public Health Service 
Act (42 U.S.C. 262(k)). 
(3) COVERED
PETITION.—The term ‘‘covered 
petition’’ means a petition, or a supplement to a pe-
tition, filed under section 505(q) of the Federal 
Food, Drug, and Cosmetic Act (21 U.S.C. 355(q)). 
(4) PERSON.—The term ‘‘person’’ means— 
(A) an individual or entity; 
(B) its directors, officers, employees, 
agents, representatives, successors, and assigns; 
and 
(C) the joint ventures, subsidiaries, part-
nerships, divisions, groups, and affiliates it con-
trols, and the respective directors, officers, em-
ployees, agents, representatives, successors, and 
assigns of each. 
VerDate Sep 11 2014 
23:32 Jun 08, 2021
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H2883.IH
H2883
kjohnson on DSK79L0C42PROD with BILLS
alty and seek other appropriate relief in a district 
court of the United States against any person that 
submitted or caused to be submitted such covered 
petition or such series of covered petitions, including 
successors or assigns. 
(2) PRESUMPTION.—In a civil action under 
paragraph (1), a covered petition shall be presumed 
to be part of a series of covered petitions that is a 
sham under subsection (b) of this section if the Sec-
retary of Health and Human Services has deter-
mined that the covered petition was submitted with 
the primary purpose of delaying the approval of a 
covered application, was part of a series of covered 
petitions, and has referred such determination to the 
Federal Trade Commission in writing, with a rea-
soned basis for the determination. 
(3) EXCEPTION.—The presumption in para-
graph (2) shall not apply if the defendant estab-
lishes, by a preponderance of the evidence, that the 
series of covered petitions that includes the covered 
petition referred to the Commission by the Secretary 
of Health and Human Services is not a sham. 
(4) CIVIL PENALTY.—In an action under para-
graph (1), any person that has been found liable for 
a violation of section 5(a)(1) of the Federal Trade 
VerDate Sep 11 2014 
23:32 Jun 08, 2021
Jkt 019200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H2883.IH
H2883
kjohnson on DSK79L0C42PROD with BILLS
Commission Act (15 U.S.C. 45(a)(1)) shall be sub-
ject to a civil penalty for each violation of not more 
than the greater of— 
(A) any revenue earned from the sale by 
such person of any drug product, referenced in 
a covered application that was the subject of a 
covered petition or a series of covered petitions 
that is a sham, during the period in which the 
covered petition or series of covered petitions 
was under review by the Secretary of Health 
and Human Services; or 
(B) $50,000 for each calendar day that 
each covered petition that is a sham or that was 
part of a series of covered petitions that is a 
sham was under review by the Secretary of 
Health and Human Services. 
(5) ANTITRUST LAWS.—Nothing in this section 
shall modify, impair, limit, or supersede the applica-
bility of the antitrust laws as defined in subsection 
(a) of the first section of the Clayton Act (15 U.S.C. 
12(a)), and of section 5 of the Federal Trade Com-
mission Act (15 U.S.C. 45) to the extent that it ap-
plies to unfair methods of competition. 
(6) RULE OF CONSTRUCTION.—The civil pen-
alty provided in this subsection is in addition to, and 
VerDate Sep 11 2014 
23:32 Jun 08, 2021
Jkt 019200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H2883.IH
H2883
kjohnson on DSK79L0C42PROD with BILLS
not in lieu of, any other remedies provided by Fed-
eral law, including under section 16 of the Clayton 
Act (15 U.S.C. 26) or under section 13(b) of the 
Federal Trade Commission Act (15 U.S.C. 53(b)). 
Nothing in this paragraph shall be construed to af-
fect any authority of the Commission under any 
other provision of law. 
(d) APPLICABILITY.—This section shall apply to any 
covered petition submitted on or after the date of enact-
ment of this Act. 
SEC. 3. SEVERABILITY. 
If any provision of this Act, an amendment made by 
this Act, or the application of such provision or amend-
ment to any person or circumstance is held to be unconsti-
tutional, the remainder of this Act, the amendments made 
by this Act, and the application of the provisions of such 
Act or amendments to any person or circumstance shall 
not be affected. 
Æ 
VerDate Sep 11 2014 
23:32 Jun 08, 2021
Jkt 019200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6301
E:\BILLS\H2883.IH
H2883
kjohnson on DSK79L0C42PROD with BILLS